Canada

Canada

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.71 (1.57 - 1.87) 2019 Modelled IHME
1.72 (1.58 - 1.86) 2018 Modelled IHME
1.73 (1.59 - 1.88) 2017 Modelled IHME
1.74 (1.60 - 1.89) 2016 Modelled IHME
1.75 (1.61 - 1.91) 2015 Modelled IHME
1.76 (1.62 - 1.91) 2014 Modelled IHME
1.77 (1.63 - 1.92) 2013 Modelled IHME
1.78 (1.63 - 1.92) 2012 Modelled IHME
1.79 (1.63 - 1.94) 2011 Modelled IHME
1.79 (1.63 - 1.95) 2010 Modelled IHME
1.8 (1.64 - 1.95) 2009 Modelled IHME
1.81 (1.65 - 1.95) 2008 Modelled IHME
1.81 (1.66 - 1.96) 2007 Modelled IHME
1.82 (1.66 - 1.97) 2006 Modelled IHME
1.82 (1.66 - 1.98) 2005 Modelled IHME
1.83 (1.67 - 1.98) 2004 Modelled IHME
1.83 (1.68 - 1.99) 2003 Modelled IHME
1.84 (1.70 - 2) 2002 Modelled IHME
1.85 (1.70 - 2.01) 2001 Modelled IHME
1.85 (1.71 - 2.02) 2000 Modelled IHME
1.86 (1.72 - 2.03) 1999 Modelled IHME
1.87 (1.73 - 2.04) 1998 Modelled IHME
1.88 (1.74 - 2.05) 1997 Modelled IHME
1.89 (1.74 - 2.07) 1996 Modelled IHME
1.9 (1.74 - 2.08) 1995 Modelled IHME
1.91 (1.75 - 2.08) 1994 Modelled IHME
1.91 (1.75 - 2.10) 1993 Modelled IHME
1.92 (1.76 - 2.10) 1992 Modelled IHME
1.92 (1.76 - 2.11) 1991 Modelled IHME
1.92 (1.75 - 2.12) 1990 Modelled IHME
2.22 (1.71 - 2.81) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.27 (0.20 - 0.34) 2019 Modelled IHME
0.28 (0.22 - 0.35) 2018 Modelled IHME
0.3 (0.23 - 0.38) 2017 Modelled IHME
0.31 (0.24 - 0.39) 2016 Modelled IHME
0.33 (0.25 - 0.41) 2015 Modelled IHME
0.35 (0.26 - 0.44) 2014 Modelled IHME
0.37 (0.28 - 0.47) 2013 Modelled IHME
0.4 (0.31 - 0.51) 2012 Modelled IHME
0.43 (0.33 - 0.56) 2011 Modelled IHME
0.47 (0.36 - 0.60) 2010 Modelled IHME
0.51 (0.39 - 0.65) 2009 Modelled IHME
0.56 (0.44 - 0.72) 2008 Modelled IHME
0.61 (0.48 - 0.79) 2007 Modelled IHME
0.66 (0.51 - 0.85) 2006 Modelled IHME
0.69 (0.54 - 0.88) 2005 Modelled IHME
0.71 (0.55 - 0.89) 2004 Modelled IHME
0.72 (0.56 - 0.90) 2003 Modelled IHME
0.73 (0.57 - 0.91) 2002 Modelled IHME
0.74 (0.58 - 0.92) 2001 Modelled IHME
0.75 (0.59 - 0.94) 2000 Modelled IHME
0.76 (0.59 - 0.95) 1999 Modelled IHME
0.77 (0.60 - 0.97) 1998 Modelled IHME
0.78 (0.60 - 0.98) 1997 Modelled IHME
0.79 (0.61 - 1) 1996 Modelled IHME
0.8 (0.61 - 1.02) 1995 Modelled IHME
0.81 (0.61 - 1.03) 1994 Modelled IHME
0.82 (0.62 - 1.04) 1993 Modelled IHME
0.82 (0.62 - 1.05) 1992 Modelled IHME
0.83 (0.63 - 1.06) 1991 Modelled IHME
0.83 (0.63 - 1.08) 1990 Modelled IHME
1.03 (0.72 - 1.42) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
6 (4 - 10) 2019 Modelled IHME
7 (4 - 10) 2018 Modelled IHME
7 (4 - 10) 2017 Modelled IHME
7 (5 - 10) 2016 Modelled IHME
7 (5 - 10) 2015 Modelled IHME
7 (5 - 10) 2014 Modelled IHME
7 (5 - 10) 2013 Modelled IHME
7 (5 - 10) 2012 Modelled IHME
7 (5 - 10) 2011 Modelled IHME
7 (5 - 10) 2010 Modelled IHME
7 (5 - 10) 2009 Modelled IHME
7 (5 - 10) 2008 Modelled IHME
7 (5 - 10) 2007 Modelled IHME
7 (5 - 10) 2006 Modelled IHME
7 (5 - 11) 2005 Modelled IHME
7 (5 - 11) 2004 Modelled IHME
7 (5 - 11) 2003 Modelled IHME
7 (5 - 11) 2002 Modelled IHME
7 (5 - 11) 2001 Modelled IHME
8 (5 - 11) 2000 Modelled IHME
8 (5 - 11) 1999 Modelled IHME
8 (5 - 11) 1998 Modelled IHME
8 (5 - 11) 1997 Modelled IHME
8 (5 - 11) 1996 Modelled IHME
8 (5 - 11) 1995 Modelled IHME
8 (5 - 11) 1994 Modelled IHME
8 (5 - 11) 1993 Modelled IHME
8 (5 - 11) 1992 Modelled IHME
8 (5 - 11) 1991 Modelled IHME
8 (5 - 11) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
71 2018 Survey/reported WHO/UNICEF
71 2017 Survey/reported WHO/UNICEF
70 2016 Survey/reported WHO/UNICEF
69 2015 Survey/reported WHO/UNICEF
55 2014 Survey/reported WHO/UNICEF
55 2013 Survey/reported WHO/UNICEF
70 2012 Survey/reported WHO/UNICEF
70 2011 Survey/reported WHO/UNICEF
56 2010 Survey/reported WHO/UNICEF
42 2009 Survey/reported WHO/UNICEF
28 2008 Survey/reported WHO/UNICEF
14 2007 Survey/reported WHO/UNICEF
14 2006 Survey/reported WHO/UNICEF
14 2005 Survey/reported WHO/UNICEF
14 2004 Survey/reported WHO/UNICEF
14 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
148 (129 - 174) 2015 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
No policy
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.93 (0.75 - 1.13) 2019 Modelled IHME
0.94 (0.78 - 1.13) 2018 Modelled IHME
0.94 (0.77 - 1.13) 2017 Modelled IHME
0.92 (0.75 - 1.11) 2016 Modelled IHME
0.9 (0.73 - 1.09) 2015 Modelled IHME
0.9 (0.73 - 1.09) 2014 Modelled IHME
0.9 (0.73 - 1.09) 2013 Modelled IHME
0.9 (0.74 - 1.09) 2012 Modelled IHME
0.9 (0.73 - 1.09) 2011 Modelled IHME
0.9 (0.73 - 1.10) 2010 Modelled IHME
0.89 (0.72 - 1.07) 2009 Modelled IHME
0.86 (0.70 - 1.04) 2008 Modelled IHME
0.83 (0.68 - 0.99) 2007 Modelled IHME
0.8 (0.66 - 0.97) 2006 Modelled IHME
0.79 (0.65 - 0.95) 2005 Modelled IHME
0.79 (0.65 - 0.95) 2004 Modelled IHME
0.79 (0.65 - 0.96) 2003 Modelled IHME
0.8 (0.66 - 0.97) 2002 Modelled IHME
0.8 (0.66 - 0.98) 2001 Modelled IHME
0.8 (0.66 - 0.98) 2000 Modelled IHME
0.8 (0.66 - 0.98) 1999 Modelled IHME
0.8 (0.66 - 0.97) 1998 Modelled IHME
0.8 (0.65 - 0.97) 1997 Modelled IHME
0.8 (0.65 - 0.96) 1996 Modelled IHME
0.8 (0.64 - 0.96) 1995 Modelled IHME
0.8 (0.64 - 0.96) 1994 Modelled IHME
0.8 (0.65 - 0.96) 1993 Modelled IHME
0.8 (0.65 - 0.97) 1992 Modelled IHME
0.8 (0.65 - 0.97) 1991 Modelled IHME
0.81 (0.66 - 0.99) 1990 Modelled IHME
0.8 (0.50 - 1) 2014 Modelled Gower et al, 2014
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.1 (0.60 - 1.30) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
70.6 (60.10 - 65.40) 2014 Modelled Degenhardt L et al, 2017

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
20 (14 - 26) 2019 Modelled IHME
19 (14 - 26) 2018 Modelled IHME
20 (14 - 26) 2017 Modelled IHME
20 (14 - 27) 2016 Modelled IHME
20 (14 - 27) 2015 Modelled IHME
20 (14 - 27) 2014 Modelled IHME
20 (14 - 27) 2013 Modelled IHME
20 (14 - 27) 2012 Modelled IHME
20 (14 - 27) 2011 Modelled IHME
20 (14 - 27) 2010 Modelled IHME
20 (14 - 27) 2009 Modelled IHME
20 (14 - 27) 2008 Modelled IHME
20 (14 - 27) 2007 Modelled IHME
20 (14 - 27) 2006 Modelled IHME
20 (14 - 27) 2005 Modelled IHME
20 (14 - 27) 2004 Modelled IHME
20 (14 - 27) 2003 Modelled IHME
20 (14 - 27) 2002 Modelled IHME
20 (14 - 27) 2001 Modelled IHME
20 (14 - 27) 2000 Modelled IHME
20 (14 - 26) 1999 Modelled IHME
20 (14 - 26) 1998 Modelled IHME
19 (13 - 26) 1997 Modelled IHME
19 (13 - 26) 1996 Modelled IHME
19 (13 - 25) 1995 Modelled IHME
19 (13 - 25) 1994 Modelled IHME
19 (13 - 25) 1993 Modelled IHME
19 (13 - 25) 1992 Modelled IHME
18 (13 - 25) 1991 Modelled IHME
18 (13 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (129 - 174) 2015 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
No policy
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
1.71 (%)
2019
(1.57 - 1.87(%))
IHME
HCV (RNA/cAg+)
0.93 (%)
2019
(0.75 - 1.13(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
445
2019
(332 - 575)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,692
2019
(2,122 - 3,311)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.27 (%)
2019, latest modelled
(0.20 - 0.34(%))
IHME

Prevalence PWID

HCV
70.60 (%)
2014, latest modelled
(60.10 - 65.40(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
148
2015
(129 - 174)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources